Imvacs
Imvacs

Speaker Faculty

  • Haritha Adhikarla, Ph.D., Associate Research Scientist, Albert Ko Laboratory, Yale School of Public Health
  • Carl Alving, M.D., Chief, Laboratory of Adjuvant & Antigen Research, U.S. Military HIV Research Program, Walter Reed Army Institute of Research
  • Maria Baca-Estrada, Ph.D., Chief, Bacterial & Combination Vaccines, Centre for Biologics Evaluation, Health Canada
  • Adam Buckley, MBA, Vice President, VBI Vaccines, Inc.
  • Dennis Christensen, Ph.D., Senior Scientist & Head, Vaccine Adjuvant Research Group, Infectious Disease Immunology, Division of Vaccines, Statens Serum Institute
  • Simon Delagrave, Ph.D., Senior Director, Head of Virology Research North America, Sanofi Pasteur
  • Antu K. Dey, D.Phil., Senior Director, R&D, Vaccine Product Development Center, International AIDS Vaccine Initiative
  • Arnaud Didierlaurent, Ph.D., Director, Translational Research & Adjuvant, GlaxoSmithKline Vaccines
  • Ali Fattom, Ph.D., Senior Vice President, Vaccine R&D, NanoBio
  • Timothy Fouts, Ph.D., Senior Director, Profectus BioSciences
  • Laurent M. Humeau, Ph.D., Vice President, Research & Development, Inovio Pharmaceuticals
  • Nicholas Jackson, Ph.D., Vice President, Head of Research, Sanofi Pasteur
  • Robert Johnson, Ph.D., Director, Office of Regulatory Affairs, Acting Director, Office of Clinical Research Resources, DMID/NIAID/NIH
  • Amine Kamen, Ph.D., Professor, Bioengineering, McGill University
  • Ming-Chung Kan, Ph.D., CEO, Vaxsia Biomedical
  • Takashi K. Kishimoto Ph.D., CSO, Selecta Biosciences
  • Harold Kleanthous, Ph.D., Head, Discovery Research, Sanofi Pasteur
  • Dennis Klinman, M.D., Ph.D., Senior Investigator, Cancer and Inflammation Program, National Cancer Institute, National Institutes of Health
  • Lakshmi Krishnan, Ph.D., Director, Immunobiology & Program Leader, Vaccines and Immunotherapeutics, National Research Council-Human Health Therapeutics, Canada
  • Ofer Levy, M.D., Ph.D., Director, Precision Vaccines Program, Boston Children’s Hospital; Associate Professor, Pediatrics, Harvard Medical School
  • Shan Lu, M.D., Ph.D., Professor, Medicine, University of Massachusetts Medical School
  • Matthias Oberli, Ph.D., Research Associate, Langer Lab, David H. Koch Institute for Integrative Cancer Research, MIT
  • Derek O’Hagan, Ph.D., Head, Global Discovery Support & New Technologies, GlaxoSmithKline Vaccines
  • Shan Lu, M.D., Ph.D., Professor, Medicine, University of Massachusetts Medical School
  • Michael McVoy, Ph.D., Professor, Pediatrics, Virginia Commonwealth University
  • Annie Mo, Ph.D., Program Officer, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Yawei Ni, Ph.D., President & CSO, KJ Biosciences
  • Nikolai Petrovsky, MBBS, Ph.D., Chairman & Research Director, Vaxine; Professor, Flinders University
  • Mark Poznansky, M.D., Ph.D., Associate Professor, Medicine, Harvard Medical School; Director, Vaccine & Immunotherapy Center, Massachusetts General Hospital
  • Peter Pushko, Ph.D., President & CSO, Medigen
  • Philip Santangelo, Ph.D., Associate Professor, Biomedical Engineering, Georgia Tech
  • Ethan Settembre, Ph.D., Head, Research, Seqirus
  • Mario Skiadopoulos, Ph.D., Senior Director, Non-Clinical Development, Emergent BioSolutions
  • Ioanna Skountzou, M.D., Ph.D., Associate Professor, Microbiology and Immunology, Emory University School of Medicine
  • Karina Smolyar, Formulation Development, Infectious Disease Research Institute
  • Gokul Swaminathan, Ph.D., Senior Scientist, Infectious Diseases & Vaccines, Merck Research Laboratories, Merck & Co., Inc.
  • Sonia Trépanier, Ph.D., Senior Director, Clinical Studies, Medicago
  • Jeffrey Ulmer, Ph.D., Head, Preclinical R&D US, GSK Vaccines
  • Dai Wang, Ph.D., Principal Scientist, Infectious Diseases and Vaccines, Merck Research Laboratory
  • William Watt, Ph.D., President & CEO, EpiThany, Inc.; University of Washington Tumor Vaccine Group
  • Ron Weiss, Ph.D., Professor, Biological Engineering, MIT
  • Lee M. Wetzler, M.D., Co-Director for Research, Section of Infectious Diseases, Professor of Medicine and Microbiology, Boston University School of Medicine
  • Jens Wrammert, Ph.D., Assistant Professor, Microbiology & Immunology, Emory University School of Medicine
  • Jian Yan, Ph.D., Associate Director, Antigen Discovery and Design, Inovio Pharmaceuticals
  • Darin Zehrung, Program Advisor, Vaccine & Pharmaceutical Delivery Technologies, PATH